tiprankstipranks
Trending News
More News >
Lixte Biotechnology Holdings, Inc. (LIXT)
:LIXT
US Market
Advertisement

Lixte Biotechnology Holdings (LIXT) Financial Statements

Compare
85 Followers

Lixte Biotechnology Holdings Financial Overview

Lixte Biotechnology Holdings's market cap is currently $10.74M. The company's EPS TTM is $-1.594; its P/E ratio is ―; Lixte Biotechnology Holdings is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -3.57M$ -5.09M$ -6.31M$ -6.72M$ -3.27M
EBITDA$ -3.57M$ 3.21K$ -1.05K$ -7.95K$ 1.56K
Net Income$ -3.59M$ -5.09M$ -6.31M$ -6.73M$ -3.26M
Balance Sheet
Cash & Short-Term Investments$ 1.04M$ 4.20M$ 5.35M$ 4.82M$ 5.07M
Total Assets$ 1.15M$ 4.31M$ 5.56M$ 5.09M$ 5.23M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.04M$ -4.20M$ -5.35M$ -4.82M$ -5.07M
Total Liabilities$ 318.28K$ 313.86K$ 394.79K$ 302.93K$ 216.52K
Stockholders' Equity$ 827.22K$ 3.99M$ 5.17M$ 4.79M$ 5.01M
Cash Flow
Free Cash Flow$ -3.16M$ -4.29M$ -4.61M$ -4.14M$ -2.13M
Operating Cash Flow$ -3.16M$ -4.29M$ -4.61M$ -4.14M$ -2.13M
Investing Cash Flow$ 0.00$ 0.00$ 5.14M$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 3.14M$ 5.14M$ 3.90M$ 4.60M
Currency in USD

Lixte Biotechnology Holdings Earnings and Revenue History

Lixte Biotechnology Holdings Debt to Assets

Lixte Biotechnology Holdings Cash Flow

Lixte Biotechnology Holdings Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis